Cascades Q2 2026 slides: packaging recovery drives margin expansion

Cascades’ Q2 2026 adjusted EPS of CAD 0.24 handily beat the CAD 0.065 consensus (+269%) as stock jumped 7.92% to CAD 15.40, near the 52-week high. Revenue rose to CAD 1.219B (+8% sequentially), with adjusted EBITDA up 19% QoQ to CAD 140M and EBITDA margin expanding 100bps to 11.5%, driven by packaging margin recovery (to 15.5%). The company also generated adjusted free cash flow of CAD 47M (CAD 0.46/sh) after CAD 61M capex, while maintaining 2026 capex guidance of CAD 150–175M and leverage at 3.3x net debt/EBITDA (above the 2.5–3.0x target). Q3 guidance calls for consolidated adjusted EBITDA of CAD 155–165M, with packaging EBITDA of CAD 135–140M, partially offset by higher logistics/recycled fiber costs and tariff-related uncertainty.

Analysis

This is less a “beat-and-raise” story than a balance-sheet repair story finally showing through in the equity. The core mechanism is operating leverage: once utilization and mix normalize, incremental gross profit falls quickly to FCF, so the next 1-2 quarters matter more than the last print. That said, the market is likely underestimating how fragile the margin bridge is to freight, OCC, and recycled-fiber inflation; if pricing lags even one quarter, the apparent step-up in EBITDA can flatten fast.

The winners are upstream logistics and recycled-fiber suppliers if volumes keep running hot, but the bigger second-order effect is on North American corrugated competitors: share gains by one player usually come with more aggressive commercial defense elsewhere, which can cap industry pricing power into Q4. The losers are levered paper/packaging equities with similar cost exposure but weaker execution, because this print raises the bar for “turnaround” credibility across the group.

Risk is asymmetrical because the equity still trades like a stressed credit. The short-term catalyst is Q3 pricing realization; the 1-3 month question is whether the margin expansion is repeatable or just a catch-up quarter. Over 6-18 months, leverage reduction is the real rerating trigger; until net debt/EBITDA moves decisively below 3.0x, the dividend yield is more a warning flag than a support. Consensus may be overpricing the durability of the recovery and underpricing the chance that asset-sale timing slips again or that tariffs force suboptimal network moves.

Key Decisions for Investors

• Buy CAS.TO only on pullbacks into CAD 14.90-15.00 ahead of the Q3 print; target CAD 16.25-16.50 if management confirms EBITDA at or above CAD 155M and leverage trends below 3.2x.
• Do not chase strength above CAD 15.40-15.45; near the 52-week high, risk/reward is poor because any miss on pricing, OCC, or logistics can compress the multiple quickly.
• Use a hard stop if CAS.TO closes below CAD 14.70 or if Q3 commentary implies margin is reverting toward ~10.5% EBITDA; that would falsify the turnaround thesis.
• Watch the credit side more than the equity side: if net debt/EBITDA does not move toward 3.0x by year-end, treat the name as a deleveraging trade, not a durable quality re-rate.
• If implied volatility is elevated, prefer a stock position with a near-term profit-taking plan over options; the catalyst path is real but the upside is likely capped unless asset-sale proceeds accelerate.